<ARTICLE> 5 <MULTIPLIER> 1,000 <PERIOD-TYPE> 9-MOS <FISCAL-YEAR-END> SEP-30-1998 <PERIOD-START> OCT-01-1997 <PERIOD-END> JUN-28-1998 <CASH> 34,472 <SECURITIES> 4,647 <RECEIVABLES> 36,110 <ALLOWANCES> (3,090) <INVENTORY> 37,173 <CURRENT-ASSETS> 132,302 <PP&E> 30,372 <DEPRECIATION> (12,432) <TOTAL-ASSETS> 155,925 <CURRENT-LIABILITIES> 37,826 <BONDS> 0 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 197 <OTHER-SE> 117,762 <TOTAL-LIABILITY-AND-EQUITY> 155,925 <SALES> 150,558 <TOTAL-REVENUES> 150,558 <CGS> 93,130 <TOTAL-COSTS> 93,130 <OTHER-EXPENSES> 72,848<F1> <LOSS-PROVISION> 790 <INTEREST-EXPENSE> 24,000 <INCOME-PRETAX> (14,953) <INCOME-TAX> (1,980) <INCOME-CONTINUING> (12,973) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (12,973) <EPS-PRIMARY> (0.66) <EPS-DILUTED> (0.66) <FN> <F1>Other expenses include $8,417 of acquired in-process research and development costs and $8,953 of merger costs and special charges. </FN>